Clinical epidemiology of parathyroidectomy in hemodialysis patients: The USRDS waves 1, 3, and 4 study

Hemodialysis International

Volumn 11, Issue 1, 2007, Pages 62-71

  Slinin, Yelena ^a   Foley, Robert N ^a,b   Collins, Allan J ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b United States Renal Data System   (United States)

Author keywords

End stage renal disease; Epidemiology and outcomes; Hemodialysis; Parathyroidectomy

Indexed keywords

ALBUMIN; CALCIUM; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ARTICLE; BONE METABOLISM; COHORT ANALYSIS; DEMOGRAPHY; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH INSURANCE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORBIDITY; MORTALITY; PARATHYROIDECTOMY; POISSON DISTRIBUTION; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; UNITED STATES;

ADULT; AGED; BONE AND BONES; DATA COLLECTION; EPIDEMIOLOGY; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; ODDS RATIO; PARATHYROIDECTOMY; RENAL DIALYSIS; RISK FACTORS;

EID: 33846377819     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2007.00155.x     Document Type: Article

References (36)

1. Malberti F, Marcelli D, Conte F, Limido A, Spotti D, Locatelli F. Parathyroidectomy in patients on renal replacement therapy: An epidemiologic study. J Am Soc Nephrol. 2001; 12: 1242-1248.
2. Cohen EP, Moulder JE. Parathyroidectomy in chronic renal failure: Has medical care reduced the need for surgery? Nephron. 2001; 89: 271-273.
3. Kestenbaum B, Seliger SL, Gillen DL, et al. Parathyroidectomy rates among United States dialysis patients: 1990-1999. Kidney Int. 2004; 65: 282-288.
4. Foley RN, Li S, Liu J, Gilbertson DT, Chen SC, Collins AJ. The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol. 2004; 16: 210-218.
5. Young EW, Albert JM, Satayathum S, et al. Predictors and consequences of altered mineral metabolism: The dialysis outcomes and practice patterns study. Kidney Int. 2005; 67: 1179-1187.
6. Jorna FH, Tobe TJ, Huisman RM, De Jong PE, Plukker JT, Stegeman CA. Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. Nephrol Dial Transplant. 2004; 19: 1168-1173.
7. Kestenbaum B, Andress DL, Schwartz SM, et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int. 2004; 66: 2010-2016.
8. Tokuyama K, Iseki K, Yoshi S, et al. An epidemiologic analysis of parathyroidectomy in chronic dialysis patients. The Okinawa Dialysis Study Group. Nippon Jinzo Gakkai Shi. 1996; 38: 309-313.
9. Fassbinder W, Brunner FP, Brynger H, et al. Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant. 1991; 6(Suppl 1):5-35.
10. Naveh-Many T, Almogi G, Livni N, Silver J. Estrogen receptors and biologic response in rat parathyroid tissue and C cells. J Clin Invest. 1992; 90: 2434-2438.
11. Sawaya BP, Monier-Faugere MC, Ratanapanichkich P, Butros R, Wedlund PJ, Fanti P. Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism. Clin Nephrol. 2002; 57: 51-55.
12. Lin CL, Hung CC, Yang CT, Huang CC. Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients. Ren Fail. 2004; 26: 289-295.
13. Lee CT, Chou FF, Chang HW, et al. Effects of parathyroidectomy on iron homeostasis and erythropoiesis in hemodialysis patients with severe hyperparathyroidism. Blood Purif. 2003; 21: 369-375.
14. Urena P, Eckardt KU, Sarfati E, et al. Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: Effect of parathyroidectomy. Nephron. 1991; 59: 384-393.
15. Yasunaga C, Matsuo K, Yanagida T, Matsuo S, Nakamoto M, Goya T. Early effects of parathyroidectomy on erythropoietin production in secondary hyperparathyroidism. Am J Surg. 2002; 183: 199-204.
16. Coen G, Calabria S, Bellinghieri G, et al. Parathyroidectomy in chronic renal failure: Short- and long-term results on parathyroid function, blood pressure and anemia. Nephron. 2001; 88: 149-155.
17. Kant KS, Cook EF, Duncan H, Freyberg R. Parathyroid hormone suppression by intravenous calcitriol: Role of phosphate, calcium, race and diabetes. Am J Med Sci. 2002; 323: 210-215.
18. Gupta A, Kallenbach LR, Zasuwa G, Divine GW. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol. 2000; 11: 330-334.
19. Dotzenrath C, Goretzki PE, Roher HD. Results of surgical therapy in renal hyperparathyroidism. Follow-up of 143 patients. Langenbecks Arch Chir. 1996; 381: 46-50.
20. Dotzenrath C, Cupisti K, Goretzki E, et al. Operative treatment of renal autonomous hyperparathyroidism: Cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg. 2003; 387: 348-354.
21. Chou FF, Lee CH, Chen HY, Chen JB, Hsu KT, Sheen-Chen SM. Persistent and recurrent hyperparathyroidism after total parathyroidectomy with autotransplantation. Ann Surg. 2002; 235: 99-104.
22. Gasparri G, Camandona M, Abbona GC, et al. Secondary and tertiary hyperparathyroidism: Causes of recurrent disease after 446 parathyroidectomies. Ann Surg. 2001; 233: 65-69.
23. Pei Y, Hercz G, Greenwood C, et al. Risk factors for renal osteodystrophy: A multivariant analysis. J Bone Miner Res. 1995; 10: 149-156.
24. Kestenbaum B, Seliger SS, Gillen DL, et al. Mortality following parathyroidectomy in the United States. [Abstract]. J Am Soc Nephrol. 2003; 14: 300A.
25. Nilsson IL, Aberg J, Rastad J, Lind L. Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism. Surgery. 2005; 137: 632-638.
26. Almqvist EG, Bondeson AG, Bondeson L, Nissborg A, Smedgard P, Svensson SE. Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery. 2002; 132: 1126-1132.
27. Stefenelli T, Abela C, Frank H, et al. Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up. J Clin Endocrinol Metab. 1997; 82: 106-112.
28. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: Incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med. 1993; 95: 197-202.
29. Kosch M, Hausberg M, Vormbrock K, et al. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res. 2000; 47: 813-818.
30. Nilsson IL, Aberg J, Rastad J, Lind L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery. 1999; 126: 1049-1055.
31. Chow KM, Szeto CC, Kum LC, et al. Improved health-related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy. J Nephrol. 2003; 16: 878-885.
32. Nagashima M, Hashimoto K, Shinsato T, et al. Marked improvement of left ventricular function after parathyroidectomy in a hemodialysis patient with secondary hyperparathyroidism and left ventricular dysfunction. Circ J. 2003; 67: 269-272.
33. Hara S, Ubara Y, Arizono K, et al. Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients. Miner Electrol Metab. 1995; 21: 72-76.
34. Di Leo C, Gallieni M, Bestetti A, et al. Cardiac and pulmonary calcification in a hemodialysis patient: Partial regression 4 years after parathyroidectomy. Clin Nephrol. 2003; 59: 59-63.
35. Drueke T, Fauchet M, Fleury J, et al. Effect of parathyroidectomy on left-ventricular function in haemodialysis patients. Lancet. 1980; 1: 112-114.
36. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42: S1-S201.